- Home
- MRNA vs PAAS Comparison
MRNA vs PAAS Comparison
Compare MRNA & PAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- PAAS
- Stock Information
- Founded
- MRNA 2010
- PAAS 1994
- Country
- MRNA United States
- PAAS Canada
- Employees
- MRNA N/A
- PAAS N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- PAAS
- Sector
- MRNA Health Care
- PAAS
- Exchange
- MRNA Nasdaq
- PAAS Nasdaq
- Market Cap
- MRNA 10.6B
- PAAS 8.8B
- IPO Year
- MRNA 2018
- PAAS 1995
- Fundamental
- Price
- MRNA $24.25
- PAAS $27.21
- Analyst Decision
- MRNA Hold
- PAAS Buy
- Analyst Count
- MRNA 20
- PAAS 4
- Target Price
- MRNA $51.94
- PAAS $31.25
- AVG Volume (30 Days)
- MRNA 8.5M
- PAAS 4.7M
- Earning Date
- MRNA 05-01-2025
- PAAS 05-07-2025
- Dividend Yield
- MRNA N/A
- PAAS 1.47%
- EPS Growth
- MRNA N/A
- PAAS N/A
- EPS
- MRNA N/A
- PAAS 0.86
- Revenue
- MRNA $3,177,000,000.00
- PAAS $2,990,700,000.00
- Revenue This Year
- MRNA N/A
- PAAS $7.17
- Revenue Next Year
- MRNA $11.16
- PAAS $7.41
- P/E Ratio
- MRNA N/A
- PAAS $31.65
- Revenue Growth
- MRNA N/A
- PAAS 18.34
- 52 Week Low
- MRNA $23.15
- PAAS $17.86
- 52 Week High
- MRNA $170.47
- PAAS $28.60
- Technical
- Relative Strength Index (RSI)
- MRNA 38.02
- PAAS 60.10
- Support Level
- MRNA $23.70
- PAAS $23.31
- Resistance Level
- MRNA $28.52
- PAAS $25.07
- Average True Range (ATR)
- MRNA 1.36
- PAAS 0.93
- MACD
- MRNA -0.09
- PAAS 0.07
- Stochastic Oscillator
- MRNA 11.11
- PAAS 99.78
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About PAAS Pan American Silver Corp.
Pan American Silver Corp is a mining company principally engaged in the operation and development of, and exploration for, silver and gold-producing properties and assets. The company's principal products are silver and gold, although it also produces and sells zinc, lead, and copper. Its operating mines comprise La Colorada, Dolores, Huaron, Morococha, Shahuindo, La Arena, Timmins West, Bell Creek, Manantial Espejo, and San Vicente mines.